Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Quattrini

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|February 15, 2019
Aldose reductase inhibitors: 2013-presentLuca Quattrini, Concettina La Motta
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 31, 2019
A 2,3-diphenylpyrido[1,2-<i>a</i>] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-αSerena Del Turco, Luca Quattrini, Rocchina Colucci, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 1, 2017
Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous interventionVito Coviello, Stefania Sartini, Luca Quattrini, et al.
Biomedicines|December 9, 2020
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable TargetLuca Quattrini, Maria Sadiq, Giovanni Petrarolo, et al.
Future Medicinal Chemistry|November 4, 2017
Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitorsKamel Metwally, Harris Pratsinis, Dimitris Kletsas, et al.
Journal of Medicinal Chemistry|April 1, 2020
Imidazo[1,2-<i>a</i>]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem CellsLuca Quattrini, Edoardo Luigi Maria Gelardi, Vito Coviello, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-<i>a</i>]pyridines against the 1A FamilyLuca Quattrini, Edoardo Luigi Maria Gelardi, Giovanni Petrarolo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 13, 2020
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activityFelicia D'Andrea, Stefania Sartini, Ilaria Piano, et al.
Cell Chemical Biology|August 21, 2018
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential InhibitorsFrancesco Balestri, Luca Quattrini, Vito Coviello, et al.
Bioorganic Chemistry|September 27, 2019
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitorsLorenzo Guazzelli, Felicia D'Andrea, Stefania Sartini, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|February 15, 2019
Aldose reductase inhibitors: 2013-presentLuca Quattrini, Concettina La Motta
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 31, 2019
A 2,3-diphenylpyrido[1,2-<i>a</i>] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-αSerena Del Turco, Luca Quattrini, Rocchina Colucci, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 1, 2017
Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous interventionVito Coviello, Stefania Sartini, Luca Quattrini, et al.
Biomedicines|December 9, 2020
Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable TargetLuca Quattrini, Maria Sadiq, Giovanni Petrarolo, et al.
Future Medicinal Chemistry|November 4, 2017
Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitorsKamel Metwally, Harris Pratsinis, Dimitris Kletsas, et al.
Journal of Medicinal Chemistry|April 1, 2020
Imidazo[1,2-<i>a</i>]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem CellsLuca Quattrini, Edoardo Luigi Maria Gelardi, Vito Coviello, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-<i>a</i>]pyridines against the 1A FamilyLuca Quattrini, Edoardo Luigi Maria Gelardi, Giovanni Petrarolo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 13, 2020
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activityFelicia D'Andrea, Stefania Sartini, Ilaria Piano, et al.
Cell Chemical Biology|August 21, 2018
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential InhibitorsFrancesco Balestri, Luca Quattrini, Vito Coviello, et al.
Bioorganic Chemistry|September 27, 2019
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitorsLorenzo Guazzelli, Felicia D'Andrea, Stefania Sartini, et al.
Pageof 2